Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry
ID: 355966Type: Forecasted
Overview

Buyer

Centers for Disease Control - NCBDDD (HHS-CDC-NCBDDD)

Award Range

$166K - $489K

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355966
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Long-term health outcomes of People Living with Spina Bifida based on the National Spina Bifida Patient Registry." This initiative aims to collect high-quality longitudinal data on individuals with spina bifida through specialized clinics and to implement the Urologic Management to Preserve Initial Renal Function Protocol for young children with myelomeningocele. The program is critical for understanding health outcomes and improving care for this population, with an estimated total funding of $2,330,000, and awards ranging from $166,428 to $488,571. Interested small businesses should note that applications are due by March 7, 2025, with an estimated award date of August 1, 2025; for further inquiries, contact Stephanie Griswold at 404-718-2623 or via email at eut6@cdc.gov.

    Point(s) of Contact
    Stephanie Griswold
    (404) 718-2623
    eut6@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Epilepsy Incidence Among Children in the United States
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Epilepsy Incidence Among Children in the United States," aimed at understanding the incidence of epilepsy among U.S. children aged 0 to 17 years. The primary objectives include estimating epilepsy incidence using comprehensive nationwide datasets, identifying risk factors associated with developing epilepsy, and examining disparities in incidence rates across various demographics and social determinants of health. This research is crucial for informing public health policies and resource allocation to improve healthcare services for affected populations. The estimated total program funding is $1.6 million, with a maximum award ceiling of $500,000, and interested applicants must submit their proposals by January 23, 2025. For further inquiries, contact Alison Amoroso at aamoroso@cdc.gov or call 470-395-2521.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Developing and Disseminating Strategies to Build Sustainable Lupus Awareness, Knowledge, Skills, and Partnerships." This initiative aims to address significant gaps in lupus awareness and care by supporting national organizations in reducing the time to diagnosis, improving care coordination, and enhancing self-management among lupus patients. The program is particularly focused on increasing healthcare provider education and promoting effective self-management tools for individuals affected by lupus, a systemic autoimmune disease that disproportionately impacts women, especially those from minority communities. The estimated total program funding is $17.5 million, with individual awards ranging from $1.4 million to $1.8 million, and applications are due by May 2, 2025. Interested applicants can reach out to Stephanie Hinton at 678-938-9722 or via email at qxk8@cdc.gov for further information.
    Improving well-being for individuals living with a blood disorder through evidence-based programs.
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control - NCBDDD is offering a federal grant opportunity aimed at improving the well-being of individuals living with blood disorders through evidence-based programs. The initiative seeks to enhance the emotional, social, and physical health of affected individuals by promoting mental health literacy and adapting programs that build psychosocial skills, ultimately aiming to reduce morbidity and improve quality of life. With an estimated total program funding of $5,925,000, the agency plans to award four cooperative agreements, with individual awards ranging from $135,000 to $450,000. Interested applicants can reach out to Dr. Fiona Bethea at gvu0@cdc.gov or by phone at 404-639-4033, with applications due by May 15, 2025, and awards expected to be announced by September 1, 2025.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.
    Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Comprehensive Analysis, Surveillance, and Statistics Initiative for Diabetes in the Young (CASSIDY)." This initiative aims to conduct surveillance of diabetes among youth under 18 years and young adults aged 18 to 44, focusing on estimating diabetes incidence and prevalence across various demographic and geographic factors to identify disparities in diabetes burden. The project will consist of two components: one for direct surveillance and another serving as a Coordinating Center to standardize methodologies and provide statistical expertise. The estimated total program funding is $12.8 million, with an award ceiling of $700,000 for up to six awards. Interested applicants can reach out to Dr. Celeste Sanders at CSanders4@cdc.gov or by phone at 770-488-2536, with applications due by January 10, 2025, and awards expected to be announced by September 30, 2025.
    Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)" through a cooperative agreement. This initiative aims to evaluate the effectiveness of existing Clinical Community Linkage (CCL) and social connectedness programs in reducing disparities related to diabetes risk factors, incidence, and complications, while also assessing the impact of various mechanisms on diabetes outcomes. The program is critical for informing future scaling of effective interventions and understanding the characteristics of successful programs, particularly for populations facing documented disparities. The estimated total program funding is $3,150,000, with an award ceiling of $350,000 and an expected three awards. Interested applicants must submit their proposals electronically by January 6, 2025, and can direct inquiries to Dr. Celeste Sanders at CSanders4@cdc.gov or by phone at 770-488-2536.
    PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) have announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) grant applications, specifically requiring clinical trials. This funding opportunity is aimed at U.S. small businesses with the necessary research capabilities to contribute to the missions of the NIH and CDC, encouraging innovation and the commercial viability of health technologies. Eligible applicants can receive funding up to $306,872 for Phase I and $2,045,816 for Phase II, with a submission deadline of April 5, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-24-246.html.
    Enhancing Timely Data Reporting, Quality, and Use in Early Hearing Detection and Intervention (EHDI) Surveillance
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control - NCBDDD is offering a funding opportunity titled "Enhancing Timely Data Reporting, Quality, and Use in Early Hearing Detection and Intervention (EHDI) Surveillance" through a cooperative agreement. The primary objective of this initiative is to support jurisdictional EHDI programs in improving data quality and utilization to enhance the screening, diagnosis, and early intervention for infants who are Deaf or Hard of Hearing (D/HH). This funding is crucial for jurisdictions to develop efficient systems for data analysis and integration, ultimately addressing gaps in timely screening and intervention services. The estimated total program funding is $35,200,000, with individual awards ranging from $200,000 to $290,000, and applications are due by March 14, 2025. For further inquiries, interested applicants can contact Deidra Green at deg4@cdc.gov or by phone at 404-498-3034.
    Innovative Approaches for TB Prevention and Case Finding to END TB
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity titled "Innovative Approaches for TB Prevention and Case Finding to END TB." This initiative aims to develop, implement, and evaluate innovative strategies for tuberculosis (TB) prevention and case finding, focusing on high-burden settings and vulnerable populations, including those living with HIV, children, and economically disadvantaged individuals. The total estimated program funding is $5 million, with an award ceiling of $1 million for up to two cooperative agreements, and applications are expected to be submitted electronically by February 27, 2025. Interested applicants can reach out to Hoang Dang at 404.639.8965 or via email at hdang@cdc.gov for further information.